A predictive signature for therapy assignment and risk assessment in prostate cancer

Désirée Bonci, Ruggero De Maria

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Prostate cancer remains the second leading cause of death in men. It is imperative to improve patient management in identifying bio-markers for personalized treatment. We demonstrated miR-15/miR-16 loss and miR-21 up-regulation and deregulation of their target genes, which represent a promising signature for ameliorating therapy assignment and risk assessment in prostate cancer.

Original languageEnglish
Pages (from-to)920-923
Number of pages4
JournalOncoscience
Volume2
Issue number11
DOIs
Publication statusPublished - 2015

Fingerprint

Prostatic Neoplasms
Cause of Death
Up-Regulation
Therapeutics
Genes

Keywords

  • Genes
  • miRNA
  • Non-coding RNA
  • Prostrate cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

A predictive signature for therapy assignment and risk assessment in prostate cancer. / Bonci, Désirée; De Maria, Ruggero.

In: Oncoscience, Vol. 2, No. 11, 2015, p. 920-923.

Research output: Contribution to journalArticle

@article{58fca3969aad4659b84a9589c7a48f87,
title = "A predictive signature for therapy assignment and risk assessment in prostate cancer",
abstract = "Prostate cancer remains the second leading cause of death in men. It is imperative to improve patient management in identifying bio-markers for personalized treatment. We demonstrated miR-15/miR-16 loss and miR-21 up-regulation and deregulation of their target genes, which represent a promising signature for ameliorating therapy assignment and risk assessment in prostate cancer.",
keywords = "Genes, miRNA, Non-coding RNA, Prostrate cancer",
author = "D{\'e}sir{\'e}e Bonci and {De Maria}, Ruggero",
year = "2015",
doi = "10.18632/oncoscience.271",
language = "English",
volume = "2",
pages = "920--923",
journal = "Oncoscience",
issn = "2331-4737",
publisher = "Impact Journals",
number = "11",

}

TY - JOUR

T1 - A predictive signature for therapy assignment and risk assessment in prostate cancer

AU - Bonci, Désirée

AU - De Maria, Ruggero

PY - 2015

Y1 - 2015

N2 - Prostate cancer remains the second leading cause of death in men. It is imperative to improve patient management in identifying bio-markers for personalized treatment. We demonstrated miR-15/miR-16 loss and miR-21 up-regulation and deregulation of their target genes, which represent a promising signature for ameliorating therapy assignment and risk assessment in prostate cancer.

AB - Prostate cancer remains the second leading cause of death in men. It is imperative to improve patient management in identifying bio-markers for personalized treatment. We demonstrated miR-15/miR-16 loss and miR-21 up-regulation and deregulation of their target genes, which represent a promising signature for ameliorating therapy assignment and risk assessment in prostate cancer.

KW - Genes

KW - miRNA

KW - Non-coding RNA

KW - Prostrate cancer

UR - http://www.scopus.com/inward/record.url?scp=84958757548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958757548&partnerID=8YFLogxK

U2 - 10.18632/oncoscience.271

DO - 10.18632/oncoscience.271

M3 - Article

AN - SCOPUS:84958757548

VL - 2

SP - 920

EP - 923

JO - Oncoscience

JF - Oncoscience

SN - 2331-4737

IS - 11

ER -